Correction to: Luvadaxistat: A Novel Potent and Selective D-Amino Acid Oxidase Inhibitor Improves Cognitive and Social Deficits in Rodent Models for Schizophrenia

Affiliations

• ¹ Neuroscience Drug Discovery Unit, Takeda, Cambridge, UK.
• ² Division of Neurosciences, Pablo de Olavide University, Seville, Spain.
• ³ Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, UK.
• ⁴ Neuroscience Drug Discovery Unit, Takeda California, 9625 Towne Centre Dr, San Diego, CA, 92121, USA. jordiserrats@gmail.com.
• ⁵ Takeda Pharmaceuticals Company Limited, Fujisawa, Kanagawa, Japan.